Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Reproductive Health
Published in: Reproductive Health 1/2013

Open Access 01-12-2013 | Research

There is no relationship between Paraoxonase serum level activity in women with endometriosis and the stage of the disease: an observational study

Authors: Felipe Barca Bragatto, Caio Parente Barbosa, Denise Maria Christofolini, Carla Peluso, Aline Amaro dos Santos, Fernanda Abani Mafra, Viviane Cavalcanti, Sonia Hix, Bianca Bianco

Published in: Reproductive Health | Issue 1/2013

Login to get access

Abstract

Background

Endometriosis is a chronic condition whose pathophysiology is unknown, but there is evidence suggesting a link with oxidative stress. Paraoxonase is a serum enzyme which circulates associated with high-density lipoprotein (HDL). It acts protecting HDL and LDL of lipid peroxidation. We aimed to compare the serum levels of PON-1 activity in women with endometriosis in different stages of the disease (minimal/mild and moderate/severe).

Methods

80 infertile women with endometriosis diagnosed by laparoscopy/laparotomy with histologic confirmation of the disease were divided according to the American Society for Reproductive Medicine classification in minimal/mild (n = 33) and moderate/severe (n = 47) cases. Paraoxonase activity and arilesterase activity were measured by spectrophotometry. Body mass index and fasting glucose levels were also determined.

Results

The paraoxonase activity were 191.29 ± 22.41 U/l in women with minimal/mild endometriosis and 224.85 ± 21.50 U/l in women with moderate/severe disease (P = 0.274). Considering arilesterase level, the results showed 89.82 ± 4.61 U/l in women with minimal/mild endometriosis and 90.78 ± 3.43 U/l in moderate/severe disease (P = 0.888).

Conclusions

Evidence of lower paraoxonase activity in women with endometriosis was not found in this study. Besides, no difference was found considering minimal/mild or moderate/severe endometriosis.
Literature
1.
Barbosa CP, Souza AM, Bianco B, Christofolini D, Mafra FA, Lima GR: Frequency of endometriotic lesions in peritoneum samples from asymptomatic fertile women and correlation with CA125 values. Sao Paulo Med J. 2009, 127: 342-345. 10.1590/S1516-31802009000600004.CrossRefPubMed
2.
Barbosa CP, Souza AM, Bianco B, Christofolini D: The effects of hormones on endometriosis development. Minerva Ginecol. 2011, 63: 375-386.
3.
Barbosa CP, de Souza AM, Bianco B, Christofolini D, Mafra FA, Lima GR: OC-125 Immunostaining in endometriotic lesion samples. Arch Gynecol Obstet. 2010, 281: 43-47. 10.1007/s00404-009-1055-7.CrossRefPubMed
4.
De Andrade AZ, Rodrigues JK, Dib LA, Romão GS, Ferriani RA, Junior AAJ, Navarro PAAS: Serum markers of oxidative stress in infertile women with endometriosis. Rev Bras Ginecol Obstet. 2010, 32: 279-285.CrossRef
5.
Cabrera JM, Zamudio LJ, Latorre EG, Orozco OC, Guerrero CH: Quantitative and qualitative peritoneal imune profiles. T-cell apoptosis and oxidative stress-associated characteristics in women with minimal and mild endometriosis. BJOG. 2011, 118: 6-16.
6.
Seeber BE, Czech T, Buchner H, Barnhart KT, Seger C, Daxenbichler G, Wildt L, Dieplinger H: The vitamin E–binding protein afamin is altered significantly in the peritoneal fluid of women with endometriosis. Fertil Steril. 2010, 94: 2923-2926. 10.1016/j.fertnstert.2010.05.008.CrossRefPubMedPubMedCentral
7.
Taylor RN, Yu J, Torres PB, Schickedanz AC, Park JK, Mueller MD, Sidell N: Mechanistic and Therapeutic Implications of Angiogenesis in Endometriosis. Reprod Sci. 2009, 16: 140-146. 10.1177/1933719108324893.CrossRefPubMed
8.
Gupta S, Agarwal A, Krajcir N, Alvarez JG: Role of oxidative stress in endometriosis. Reprod Biomed Online. 2006, 13: 126-134. 10.1016/S1472-6483(10)62026-3.CrossRefPubMed
9.
10.
Verit FF, Erel O, Celik N: Serum paraoxonase-1 activity in women with endometriosis and its relationship with the stage of the disease. Hum Reprod. 2008, 23: 100-104.CrossRefPubMed
11.
Tomás M, Elosua R, Sentí M, Molina L, Vila J, Anglada R: Paraoxonase1-192 polymorphism modulates the effects of regular and acute exercise on paraoxonase1 activity. J Lipid Research. 2002, 43: 713-720.
12.
Draganov DI, La Du BN: Pharmacogenetics of paraoxonases: a brief review, Naunyn-Schmiedeberg’s Arch. Pharmacol. 2002, 369: 78-88.
13.
La Du BN, Aviram M, Billecke S, Navab M, Primo-Parmo S, Sorenson RC, Standiford TJ: On the physiological role(s) of the paraoxonases. Chem Biol Interact. 1999, 119–120: 379-388.CrossRefPubMed
14.
Khersonsky O, Tawfik DS: Structure-Reactivity Studies of Serum Paraoxonase PON1 Suggest that Its Native Activity Is Lactonase. Biochemistry. 2005, 44: 6371-6382. 10.1021/bi047440d.CrossRefPubMed
15.
Biggadike K, Angell RM, Burgess CM, Farrell RM, Hancock AP, Harker AJ, Irving WR, Ioannou C, Procopiou PA, Shaw RE, Solanke YE, Singh OM, Snowden MA, Stubbs RJ, Walton S, Weston HE: Selective plasma hydrolysis of glucocorticoid gammalactones and cyclic carbonates by the enzyme paraoxonase: an ideal plasma inactivation mechanism. J Med Chem. 2000, 43: 19-21. 10.1021/jm990436t.CrossRefPubMed
16.
Ferretti G, Bacchetti T, Nègre-Salvayre A, Salvayre R, Dousset N, Curatola G: Structural modifications of HDL and functional consequences. Atherosclerosis. 2006, 184: 1-7. 10.1016/j.atherosclerosis.2005.08.008.CrossRefPubMed
17.
Camps J, Marsillach J, Joven J: The paraoxonases: role in human diseases and methodological difficulties in measurement. Crit Rev Clin Lab Sci. 2009, 46: 83-106. 10.1080/10408360802610878.CrossRefPubMed
18.
Rozenberg O, Rosenblat M, Coleman R, Shih DM, Aviram M: Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice. Free Radic Biol Med. 2003, 34: 774-778. 10.1016/S0891-5849(02)01429-6.CrossRefPubMed
19.
Rozemberg O, Shih DM, Aviram M: Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice. Atherosclerosis. 2005, 181: 9-18. 10.1016/j.atherosclerosis.2004.12.030.CrossRef
20.
Aviram M, Rosenblat M: Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radical Biol Med. 2004, 9: 1304-1316.CrossRef
21.
Ferretti G, Bacchetti T, Moroni C, Savino S, Liuzzi A, Balzola F, Bicchiega V: Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females. J Clin Endocrinol Metab. 2005, 3: 1728-1733.CrossRef
22.
Rosenblat M, Vaya J, Shih DM, Aviram M: Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine. Atherosclerosis. 2005, 179: 69-77. 10.1016/j.atherosclerosis.2004.10.028.CrossRefPubMed
23.
She M, Chen H, Yan Y, Li H, Liu D: The human paraoxonase gene cluster as a target in the treatment of atherosclerosis. Antioxid Redox Signal. 2012, 16: 597-632. 10.1089/ars.2010.3774.CrossRefPubMedPubMedCentral
24.
Gur M, Aslan M, Yildiz A, Demirbag R, Yilmaz R, Selek S, Erel O, Ozdogru I: Paraoxonase and arylesterase activities in coronary artery disease. Eur J Clin Invest. 2006, 36: 779-787. 10.1111/j.1365-2362.2006.01727.x.CrossRefPubMed
25.
Marsillach J, Camps J, Beltran-Debón R, Rull A, Aragones G, Maestre-Martínez C, Sabench F, Hernández M, Castillo DD, Joven J, Mackness M, Mackness B: Immunohistochemical analysis of paraoxonases-1 and 3 in human atheromatous plaques. Eur J Clin Invest. 2011, 41: 308-314. 10.1111/j.1365-2362.2010.02411.x.CrossRefPubMed
26.
Revised American Society for Reproductive Medicine classification of endometriosis. Fertil Steril. 1997, 67: 817-821. 10.1016/S0015-0282(97)81391-X.
27.
28.
Ozenoglu A, Balci H, Ugurlu S, Caglar E, Uzun H, Sarkis C, Gunay C, E, EE: The relationships of leptin, adiponectin levels and paraoxonase activity with metabolic and cardiovascular risk factors in females treated with psychiatric drugs. Clinics (Sao Paulo). 2008, 63: 651-660. 10.1590/S1807-59322008000500014.CrossRef
29.
Davis K, Crow J, Chambers H, Meek E, Chambers J: Racial Differences in Paraoxonase-1 (PON1): A Factor in the Health of Southerners?. Environ Health Perspect. 2009, 117: 1226-1238.CrossRefPubMedPubMedCentral
30.
Ikeda Y, Suehiro T, Inoue M, Nakauchi Y, Morita T, Arii K: Serum paraoxonase activity and its relationship to diabetic complications in patients with non–insulin-dependent diabetes mellitus. Metabolism. 1998, 47: 598-602. 10.1016/S0026-0495(98)90246-3.CrossRefPubMed
31.
Dirican M, Akca R, Darandol E, Dilek K: Serum paraoxonase activity in uremic predialysis and hemodialysis patients. J Nephrol. 2004, 17: 813-818.PubMed
32.
Gur M, Aslan M, Yildiz A, Demirbag R: Paraoxonase and arylesterase activities in coronary artery disease. Eur J Clin Invest. 2006, 36: 779-787. 10.1111/j.1365-2362.2006.01727.x.CrossRefPubMed
33.
Brites F, Zago V, Verona J, Muzzio ML, Wikinski R, Schreier L: HDL capacity to inhibit LDL oxidation in well-trained triathletes. Life Sci. 2006, 78: 3074-3081. 10.1016/j.lfs.2005.12.015.CrossRefPubMed
34.
Pretta S, Remorgida V, Abbamonte LH, Anserini P, Ragni N, Del Sette M, Gandolfo C, Ferrero S: Atherosclerosis in women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2007, 132: 226-231. 10.1016/j.ejogrb.2006.04.015.CrossRefPubMed
35.
Melo A, Rosa-e-Silva C, Rosa-e-Silva A, Poli-Neto O, Ferriani R, Vieira C: Unfavorable lipid profile in women with endometriosis. Fertil Steril. 2010, 93: 2433-2436. 10.1016/j.fertnstert.2009.08.043.CrossRefPubMed
36.
Agarwal A, Saleh RA, Bedaiwy MA: Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil Steril. 2003, 79: 829-843. 10.1016/S0015-0282(02)04948-8.CrossRefPubMed
37.
Szczepanska M, Kozlik J, Skrzypczak J, Mikolajczyk M: Oxidative stress may be a piece in the endometriosis puzzle. Fertil Steril. 2003, 79: 1288-1293. 10.1016/S0015-0282(03)00266-8.CrossRefPubMed
38.
Gupta S, Krajcir N, Alvarez JG, Agarwal: Role of oxidative stress in endometriosis. Reprod Biomed Online. 2006, 13: 126-134. 10.1016/S1472-6483(10)62026-3.CrossRefPubMed
39.
Gupta S, Goldberg JM, Aziz N, Goldberg E, Krajcir N, Agarwal A: Pathogenic mechanisms in endometriosis-associated infertility. Fertil Steril. 2008, 90: 247-257. 10.1016/j.fertnstert.2008.02.093.CrossRefPubMed
40.
Andrade AZ, Rodrigues JK, Dib LA, Romão GS, Ferriani RA, Jordão Junior AA, Navarro PA: Serum markers of oxidative stress in infertile women with endometriosis. Rev Bras Ginecol Obstet. 2010, 32: 279-285.CrossRefPubMed
41.
Augoulea A, Mastorakos G, Lambrinoudaki I, Christodoulakos G, Creatsas G: The role of the oxidative-stress in the endometriosis-related infertility. Gynecol Endocrinol. 2009, 25: 75-81. 10.1080/09513590802485012.CrossRefPubMed
42.
Alpay Z, Saed GM, Diamond MP: Female infertility and free 11. radicals: potential role in adhesions and endometriosis. J Soc Gynecol Investig. 2006, 13: 390-398. 10.1016/j.jsgi.2006.05.002.CrossRefPubMed
43.
Rebelatto JR, Jiménez R, Delgado MA, Muguerza B, Muñoz ME, Galan AI, Sánchez RM, Arenillas JIC: Antioxidants. Physical Activity and Oxidative Stress in Older Women. Rev Bras Med Esporte. 2008, 14: 8-11.
44.
Mohamed A, Chia S: Interethnic variability of plasma paraoxonase (PON1) activity towards organophosphates and PON1 polymorphisms among Asian populations–a short review. Ind Health. 2008, 46: 309-317. 10.2486/indhealth.46.309.CrossRef
45.
Sarandöl E, Dirican M, Eröz E, Kırhan E, Serdar Z: Uncu. Serum Paraoxonase and Arylesterase Activities Throughout normal pregnancy. Nobel Medicus. 2010, 19: 49-55.
46.
Mackness B, Beltran-Debon R, Aragones G, Joven J, Camps J, Mackness M: Human tissue distribution of paraoxonases 1 and 2 mRNA. IUBMB Life. 2010, 62: 480-482.PubMed
47.
Camps J, García-Heredia A, Rull A, Alonso-Villaverde C, Aragonès G, Beltrán-Debón R, Rodríguez-Gallego E, Joven J: PPARs in Regulation of Paraoxonases: Control of Oxidative Stress and Inflammation Pathways. PPAR Res. 2012, 2012: 616371-CrossRefPubMedPubMedCentral
48.
Deakin S, Bioletto S, Bochaton-Piallat M, James R: HDL-associated paraoxonase-1 can redistribute to cell membranes and influence sensitivity to oxidative stress. Free Radic Biol Med. 2011, 1: 102-109.CrossRef
49.
James R, Deakin S: The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity. Free Radic Biol Med. 2004, 15: 1986-1994.CrossRef
Metadata
Title
There is no relationship between Paraoxonase serum level activity in women with endometriosis and the stage of the disease: an observational study
Authors
Felipe Barca Bragatto
Caio Parente Barbosa
Denise Maria Christofolini
Carla Peluso
Aline Amaro dos Santos
Fernanda Abani Mafra
Viviane Cavalcanti
Sonia Hix
Bianca Bianco
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Reproductive Health / Issue 1/2013
Electronic ISSN: 1742-4755
DOI
https://doi.org/10.1186/1742-4755-10-32

Other articles of this Issue 1/2013

Reproductive Health 1/2013 Go to the issue

Erratum

Erratum to: Knowledge of safe motherhood among women in rural communities in northern Nigeria: implications for maternal mortality reduction

Research

A retrospective analysis of maternal and neonatal mortality at a teaching and referral hospital in Kenya

Commentary

Child survival: a message of hope but a call for renewed commitment in UNICEF report

Research

Domestic violence and its predictors among married women in reproductive age in Fagitalekoma Woreda, Awi zone, Amhara regional state, North Western Ethiopia

Study protocol

Tobacco cessation intervention for pregnant women in Argentina and Uruguay: study protocol

Review

Towards elimination of maternal deaths: maternal deaths surveillance and response